Top Wall Street Forecasters Revamp DiaMedica Therapeutics Expectations Ahead Of Q4 Earnings DiaMedica Therapeutics (
NASDAQ: DMAC ) will release Q4 earnings on March 30. Analysts expect a quarterly loss of 18 cents per share. Stock fell 0.9% on Friday.
DiaMedica Therapeutics Inc (NASDAQ:DMAC) Reports Q3 2025 Earnings and Clinical Progress DiaMedica reports Q3 2025 results, advancing DM199 for stroke and preeclampsia. The company has a cash runway into H2 2027 to fund clinical trials.
DiaMedica Therapeutics Inc. (NASDAQ:DMAC) Reports Q2 2025 Earnings: Narrower Loss and Promising Clinical Updates Drive Stock Surge DiaMedica Therapeutics reports Q2 2025 results with a narrower-than-expected loss, positive clinical updates, and strong cash position. Stock surges 19% post-earnings.
DMAC Stock Earnings: DiaMedica Therapeutics Beats EPS for Q2 2024 DMAC stock results show that DiaMedica Therapeutics beat analyst estimates for earnings per share the second quarter of 2024.
DMAC Stock Earnings: DiaMedica Therapeutics Beats EPS for Q1 2024 DMAC stock results show that DiaMedica Therapeutics beat analyst estimates for earnings per share the first quarter of 2024.
DMAC Stock Earnings: DiaMedica Therapeutics Meets EPS for Q4 2023 DMAC stock results show that DiaMedica Therapeutics met analyst estimates for earnings per share the fourth quarter of 2023.
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday Pre-market stock movers are a hot topic on Wednesday and we're offering all the details that investors need to know about this morning.
Earnings Scheduled For November 13, 2023 Companies Reporting Before The Bell • Sohu.com (
NASDAQ:SOHU ) is expected to report earnings for its third quarter. • Dixie Gr (
NASDAQ:DXYN ) is estimated to report earnings for its third quarter.
